IPHA hosts digital engagement seminar as healthcare storytelling evolves

Ever wondered why Facebook is serving you more and more ads for ways to take better care of health or your video feed features patients telling their stories of recovery from serious illnesses?

Read more

Pharmaceutical industry has ‘central role’ in improving cancer services

On World Cancer Day, pharmaceutical innovators have said they have a central role in delivering better cancer services for Irish patients over the coming years.

The Irish Pharmaceutical Healthcare Association (IPHA), which represents the research-based pharmaceutical industry, called on policymakers, clinicians, researchers and industry leaders to continue to work together on improving cancer outcomes for patients.

Read more

Government recognises ‘very significant work’ by industry on Brexit planning

The Government has recognised the industry for “very significant work” in planning for Brexit.

At the Oireachtas Committee on Health on Wednesday, the Secretary General of the Department of Health, Jim Breslin, outlined the steps the health authorities, working with industry and other stakeholders, are taking to secure the supply of medicines to patients after Brexit.

Read more

European lawmakers on course to weaken IP incentives environment

Lawmakers in Brussels are on track towards weakening the environment for the discovery and adoption of medical innovation, potentially putting at risk the development of new treatments and high-quality jobs at the frontiers of research.

Read more

Brexit demands us all to work together for patients

There’s a saying in Brussels called going ‘into the tunnel’. It’s when negotiators get together to try to plot a path to resolving Brexit. As the political turmoil continues, one certainty is that pharmaceutical innovators have been meticulously planning for Brexit. For two years or more, they have been reorganising supply chains and revising regulatory approvals. This work is critical in minimising the risk of disruption to the supply of medicines to patients after March 29th.

Read more

Two-Thirds of People Say Patients’ Wait For New Medicines is ‘Unacceptable’ - Ipsos MRBI

Two-thirds of people feel it is ‘unacceptable’ that life-changing medicines are available to patients in other countries before our own can get them, according to a survey conducted by Ipsos MRBI on behalf of Irish Pharmaceutical Healthcare Association (IPHA), the organisation that represents pharmaceutical innovators in Ireland.

Read more

The pharma year unwrapped

As we near the end of the year, it’s a good time to look back on just some of the highlights of our public communications and advocacy.

Read more